ASPI Stock Risk & Deep Value Analysis
ASP Isotopes Inc
Basic Materials • Chemicals
DVR Score
out of 10
The Bottom Line on ASPI
We analyzed ASP Isotopes Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran ASPI through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.
ASPI Stock Risk Analysis
Overall Risk
Aggressive
Financial Risk
High
Market Risk
Medium
About ASP Isotopes Inc (ASPI)
Sector
Basic Materials
Industry
Chemicals
Market Cap Category
small
Market Cap
$591.57M
ASPI Deep Value Analysis
Compare ASPI to Similar Stocks
See how ASP Isotopes Inc stacks up against related companies in our head-to-head analysis.
ASPI Red Flags & Warning Signs
- âš
Delays or cost overruns in facility construction
- âš
Failure to secure significant commercial contracts
- âš
Need for additional capital leading to substantial shareholder dilution
- âš
Regulatory challenges for specific isotope applications
Unlock ASPI Red Flags & Risk Warnings
Create a free account to see the full analysis
ASPI Financial Health Metrics
Market Cap
$591.57M
ASPI Competitive Moat Analysis
Sign in to unlockMoat Rating
Narrow
Moat Trend
Expanding
Moat Sources
2 Identified
The moat is being built through the development of specialized, proprietary technology and the intricate processes required for high-purity isotope production. If successfully scaled, the high capital intensity and technical expertise will create significant barriers to entry, making it durable for 10-15 years, with potential for longer if intellectual property is rigorously defended and new applications are continually developed.
ASPI Competitive Moat Analysis
Sign up to see competitive advantages
ASPI Catalysts & Growth Drivers
Near-Term (0-6 months)
- •Q4 2025 Earnings Report (Estimated late-March 2026)
- •Updates on construction progress of key isotope production facilities
- •Announcements of initial small-scale commercial agreements or R&D partnerships
Medium-Term (6-18 months)
- •Securing major commercial supply contracts for medical or quantum computing isotopes (6-12 months)
- •Operational readiness and initial production from new facilities
- •Strategic partnerships with leading players in target industries
Long-Term (18+ months)
- •Establishment as a dominant supplier in high-purity isotope markets
- •Broader adoption of quantum computing and advanced medical diagnostics increasing demand
- •Expansion into new stable isotope applications
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
ASPI Bull Case: What Could Go Right
- ✓
Clear progress reports on facility construction and commissioning
- ✓
Announcements of multi-year, high-value commercial supply contracts
- ✓
Management's ability to maintain a healthy cash runway without excessive dilution
Bull Case Analysis
See what could go right with Premium
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.
